Cite

HARVARD Citation

    Vandeveer, G. et al. (2023). Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model. Bioorganic & medicinal chemistry letters. p. . [Online]. 
  
Back to record